Patents by Inventor Maki OKABE

Maki OKABE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11925648
    Abstract: The present invention provides a solid dosage form having good stability, suspensibility in water and fluidity by preparing a solid dosage form containing a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, a stabilizer, a sugar alcohol and/or a sugar, a water-soluble polymer and an inorganic substance.
    Type: Grant
    Filed: October 22, 2020
    Date of Patent: March 12, 2024
    Assignee: SHIONOGI & CO., LTD.
    Inventors: Naoya Mizutani, Masayuki Morimoto, Maki Okabe, Masaaki Ito, Go Kimura
  • Publication number: 20230173027
    Abstract: A pharmaceutical composition containing the substance according to any one of the following (a) to (c), an organic acid, a metal salt of an organic acid, and a sugar and/or a sugar alcohol, wherein when the pharmaceutical composition is dissolved in distilled water for injection, a pH of the pharmaceutical composition is 3.0 to 4.
    Type: Application
    Filed: April 19, 2021
    Publication date: June 8, 2023
    Applicants: Shionogi & Co., Ltd., StemRim Inc.
    Inventors: Nao MATSUOKA, Shuichi HATANO, Yuya KUGA, Maki OKABE, Takehiko YAMAZAKI, Koichi YOKOTA
  • Publication number: 20220178901
    Abstract: When the mesh is placed under the bottom of a blade and over the bottom of a vessel in the dissolution test assembly equipped with either a vessel specified in the dissolution test method of the Japanese Pharmacopoeia, the United States Pharmacopoeia or the European Pharmacopoeia or a vessel used for the dissolution test, and a paddle formed from a blade and a shaft, and the suspensions and the solid dosage forms are added to or placed at the said mesh, a drug dissolves from the said dosage forms and the dissolution ratio variation between the said multiple same dosage forms can be small.
    Type: Application
    Filed: April 7, 2020
    Publication date: June 9, 2022
    Applicant: Shionogi & Co., Ltd.
    Inventors: Kensuke HORIUCHI, Satoyo MATSUURA, Maki OKABE
  • Publication number: 20210106589
    Abstract: The present invention provides a solid dosage form having good stability, suspensibility in water and fluidity by preparing a solid dosage form containing a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, a stabilizer, a sugar alcohol and/or a sugar, a water-soluble polymer and an inorganic substance.
    Type: Application
    Filed: October 22, 2020
    Publication date: April 15, 2021
    Applicant: Shionogi & Co., Ltd.
    Inventors: Naoya MIZUTANI, Masayuki MORIMOTO, Maki OKABE, Masaaki ITO, Go KIMURA